LifeScience Clinical & Diagnostic
Lunit Secures Landmark Framework Agreement to Deploy Breast Imaging AI Across 1,500+ French Public Hospitals
Framework agreement with UniHA enables access to Lunit's breast AI solutions across 1,500+ French public hospitals, in collaboration with Fujifilm L...
September 12, 2025 | News
Telix Doses First Patient In Phase 3 BiPASS™ Trial Evaluating Illuccix® And Gozellix® For Prostate Cancer Diagnosis
Telix Pharmaceuticals Limited announces it has dosed the first patient in a Phase 3 clinical trial aimed at expanding the indications for Illuccix&re...
September 11, 2025 | News
Contrast-Enhanced Ultrasound Shows Promise for Early Pancreatic Cancer Detection
A new study shows that contrast enhanced ultrasound (CEUS) techniques offer an encouraging option for noninvasively detecting pancreatic cancer in its earl...
September 11, 2025 | Report
Metabolon Partners with China Kadoorie Biobank to Advance Landmark Multiomics Study on Common Diseases
The landmark multiomics study will examine how lifestyle, environmental, socioeconomic, and genetic factors play a significant role in shaping common disea...
September 10, 2025 | News
Epigenic Therapeutics Raises $60 Million in Series B Financing to Advance Epigenetic Medicine Pipeline
Epigenic Therapeutics ("Epigenic"), a clinical-stage innovative drug development company, today announced the completion of a $60 million Series ...
September 09, 2025 | News
Andelyn Biosciences and Tern Therapeutics Partner to Advance Gene Therapy for CLN2 Batten Disease
Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered...
September 08, 2025 | News
Acer Expands SpatialLabs Pro With NVIDIA Omniverse, Vision Engineering, and Smart Surgery Integrations
Integration with NVIDIA Omniverse libraries via OpenXR runtime supports enhanced spatial awareness for industrial designs and simulations Partnership wi...
September 04, 2025 | News
South Korea’s AMI Pharm Reports Phase 2 Success of ‘AYP-101,’ a Potential New Leader in Nonsurgical Fat Reduction
AMI Pharm's 'AYP-101' Sets to Become a New Leader in Nonsurgical Fat Reduction with Phase 2 Trial Success 'AYP-101,' a Promising Nonsurgical Solution, H...
September 02, 2025 | News
Genentech and Alnylam Advance Zilebesiran into Phase III Outcomes Trial for Hypertension
Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3 – – ...
September 02, 2025 | News
Alphamab Oncology Reports Strong H1 2025 Growth and Pipeline Advancements, Achieving Profitability
Alphamab Oncology (stock code: 9966.HK) reported interim financial results for the six months ended June 30, 2025 and highlighted recent business...
September 01, 2025 | Company results
ACROBiosystems and South Korea’s DAAN Biotherapeutics Sign Strategic MOU to Advance Precision Immuno-Oncology
ACROBiosystems, a global biotechnology company dedicated to accelerating the drug development process through innovative tools and solutions, announced tha...
August 29, 2025 | News
Basecare Medical Secures NMPA Approval For VitBase Culture Medium Marking Breakthrough In China’s Assisted Reproductive Field
Suzhou Basecare Medical Co., Ltd. achieved a major breakthrough—its globally leading Gems culture medium (embryo handling solution VitBase) has offic...
August 27, 2025 | Regulatory
iNtRON Bio Files Patents for Groundbreaking IMPA™ Gene-Editing Technology Targeting Pasteurella Bacteriophages
Development of gene-editing technology for Pasteurella bacteriophages using the IMPA™ platform Establishment of an advanced platform tec...
August 27, 2025 | News
Akeso Reports Positive Phase 3 Results For Gumokimab In Ankylosing Spondylitis And Manfidokimab In Atopic Dermatitis
Akeso Inc. announced positive results from its Phase 3 clinical trial of gumokimab (AK111), a novel, fully human anti-IL-17A monoclonal antibod...
August 26, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
